Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
BASTA JAMES
EVP, General Counsel at Intellia Therapeutics. Filing since 4 Jan 2023.
CIK 0001792726
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
2 Mar 2026
EVP, General Counsel
Sold at will
1,211
$16.69K
0.8%
NTLA
Intellia Therapeutics, Inc.
5 Jan 2026
EVP, General Counsel
Sold at will
10,397
$95.76K
9.3%
NTLA
Intellia Therapeutics, Inc.
4 Mar 2025
EVP, General Counsel
Sold at will
2,572
$23.12K
2.2%
NTLA
Intellia Therapeutics, Inc.
3 Jan 2025
EVP, General Counsel
Sold at will
7,074
$86.16K
8.7%
NTLA
Intellia Therapeutics, Inc.
4 Mar 2024
EVP, General Counsel
Sold at will
2,297
$75.78K
2.7%
NTLA
Intellia Therapeutics, Inc.
3 Jan 2024
EVP, General Counsel
Sold at will
3,805
$112.10K
6.9%
NTLA
Intellia Therapeutics, Inc.
2 Mar 2023
EVP, General Counsel
Sold, plan not stated
1,088
$47.74K
1.9%
NTLA
Intellia Therapeutics, Inc.
4 Jan 2023
EVP, General Counsel
Sold, plan not stated
1,138
$42.34K
5.5%
8 decisions on file.